Prediction Model of Diabetes Complications Based on Genetic Engineering Improved Genetic Algorithm Optimized BP Neural Network
DOI:
https://doi.org/10.62051/ijphmr.v2n1.07Keywords:
Diabetes Complications, BP Neural Network, Genetic Engineering, Improved Genetic AlgorithmAbstract
Nowadays, with the rapid development of science and technology, people’s living standards have been greatly improved, and many chronic diseases have also been brought, including diabetes. The occurrence of diabetes not only poses a serious threat to human body, but also poses a threat to human life with its development. BP (Back Propagation) neural network model can well solve the logic regression problem of single factor and multiple factors, and also better solve the collinearity problem of multiple factors. BP neural network optimized based on improved genetic algorithm can reflect the influence mode and degree of various factors, and can be predicted from the perspective of patients’ diet, exercise, and doctors’ application of insulin. In this paper, the patients in a hospital were taken as the research object, and the BP neural network method was used to analyze the causes of the disease. The prediction model was used to screen out the high-risk groups of diabetes patients and reduce their incidence rate. Secondly, according to the collected data, the relationship between diabetes related complications was analyzed in depth by using genetic engineering technology, thus providing a theoretical basis for the prevention and treatment of diabetes and its complications. The prediction accuracy of BP neural network optimized by genetic algorithm can reach 94.1%. In the high-risk group of diabetes, taking appropriate diet and behavioral measures can reduce the probability of diabetes. The prediction scheme of diabetes complications proposed in this paper is simple and its cost is low, which can greatly reduce the cost of prevention and treatment of diabetes and the probability of diabetes.
References
[1] Peters, Sanne AE, and Mark Woodward. "Sex differences in the burden and complications of diabetes." Current diabetes reports 18.6 (2018): 1-8.
[2] Pearce, Ian. "Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review." Diabetes, obesity and metabolism 21.3 (2019): 467-478.
[3] Ljubic, Branimir. "Predicting complications of diabetes mellitus using advanced machine learning algorithms." Journal of the American Medical Informatics Association 27.9 (2020): 1343-1351.
[4] Targher, Giovanni, Amedeo Lonardo, and Christopher D. Byrne. "Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus." Nature reviews endocrinology 14.2 (2018): 99-114.
[5] Harding, Jessica L.. "Global trends in diabetes complications: a review of current evidence." Diabetologia 62.1 (2019): 3-16.
[6] Jha, Jay C.. "A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes." Clinical Science 132.16 (2018): 1811-1836.
[7] Karamzad, Nahid. "A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre‐diabetes." Biofactors 46.1 (2020): 21-37.
[8] Cole, Joanne B., and Jose C. Florez. "Genetics of diabetes mellitus and diabetes complications." Nature reviews nephrology 16.7 (2020): 377-390.
[9] Menini, Stefano. "L-carnosine and its derivatives as new therapeutic agents for the prevention and treatment of vascular complications of diabetes." Current Medicinal Chemistry 27.11 (2020): 1744-1763.
[10] Hainaroșie, Razvan. "Management of infectious complications in diabetes mellitus mellitus patients." Rom J Mil Med 122.1 (2019): 46-51.
[11] Maturi, Raj K.. "Effect of intravitreous anti–vascular endothelial growth factor vs sham treatment for prevention of vision-threatening complications of diabetic retinopathy: the Protocol W Randomized Clinical Trial." JAMA ophthalmology 139.7 (2021): 701-712.
[12] Elshaer, Sally L.. "Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse." Stem Cell Research & Therapy 9.1 (2018): 1-18.
[13] Yang, Qian-Qian. "The association between diabetes complications, diabetes distress, and depressive symptoms in patients with type 2 diabetes mellitus." Clinical nursing research 30.3 (2021): 293-301.
[14] Zglejc‐Waszak, Kamila, Konark Mukherjee, and Judyta Karolina Juranek. "The cross‐talk between RAGE and DIAPH1 in neurological complications of diabetes: A review." European Journal of Neuroscience 54.6 (2021): 5982-5999.
[15] Laiteerapong, Neda. "The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the Diabetes & Aging Study)." Diabetes care 42.3 (2019): 416-426.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







